Igor Bilinsky

Companies

• Iovance BiotherapeuticsChief operating officer Mar 16, 2021 to now¹
• Oncternal Therapeutics, Inc.Chief Business Officer Sep 9, 2019 to Feb 16, 2021²
• Armata Pharmaceuticals, Inc.Chief operating officer Jan 31, 2017 to Jun 1, 2017³
• Fresh Tracks Therapeutics, Inc.Senior VP, Corporate Dev't Dec 20, 2013 to Jul 15, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IBIovance Biotherapeutics IOVA142,074 shares⁵$2.0M at $13.92Sep 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Shares withheld for tax 3,976 shares at $8.70 of Iovance Biotherapeutics⁵
• Sep 8, 2026Exercised options 7,813 shares of Iovance Biotherapeutics⁵
• Sep 1, 2026Shares withheld for tax 4,472 shares at $8.28 of Iovance Biotherapeutics⁶
• Sep 1, 2026Exercised options 8,789 shares of Iovance Biotherapeutics⁶
• Jun 5, 2026Shares withheld for tax 3,976 shares at $4.23 of Iovance Biotherapeutics⁷
• Jun 5, 2026Exercised options 7,813 shares of Iovance Biotherapeutics⁷
• Jun 1, 2026Shares withheld for tax 4,473 shares at $3.96 of Iovance Biotherapeutics⁸
• Jun 1, 2026Exercised options 8,790 shares of Iovance Biotherapeutics⁸
• Mar 5, 2026Shares withheld for tax 16,628 shares at $4.58 of Iovance Biotherapeutics⁹
• Mar 5, 2026Exercised options 31,246 shares of Iovance Biotherapeutics⁹
• Mar 2, 2026Shares withheld for tax 6,903 shares at $3.79 of Iovance Biotherapeutics¹⁰
• Mar 2, 2026Exercised options 12,307 shares of Iovance Biotherapeutics¹⁰
• Dec 2, 2025Shares withheld for tax 1,786 shares at $2.14 of Iovance Biotherapeutics¹¹
• Dec 2, 2025Exercised options 3,516 shares of Iovance Biotherapeutics¹¹
• Dec 1, 2025Shares withheld for tax 4,464 shares at $2.23 of Iovance Biotherapeutics¹¹
• Dec 1, 2025Exercised options 8,789 shares of Iovance Biotherapeutics¹¹
• Sep 2, 2025Shares withheld for tax 6,250 shares at $2.19 of Iovance Biotherapeutics¹²
• Sep 2, 2025Exercised options 12,306 shares of Iovance Biotherapeutics¹²
• Jun 2, 2025Shares withheld for tax 6,250 shares at $1.76 of Iovance Biotherapeutics¹³
• Jun 2, 2025Exercised options 12,305 shares of Iovance Biotherapeutics¹³
• Mar 3, 2025Shares withheld for tax 33,302 shares at $4.04 of Iovance Biotherapeutics¹⁴
• Mar 3, 2025Exercised options 62,106 shares of Iovance Biotherapeutics¹⁴
• Jan 14, 2025Shares withheld for tax 1,578 shares at $5.89 of Iovance Biotherapeutics¹⁵
• Jan 14, 2025Exercised options 2,813 shares of Iovance Biotherapeutics¹⁵
• Dec 2, 2024Shares withheld for tax 1,784 shares at $9.07 of Iovance Biotherapeutics¹⁶